IE
PTLA

Israel Englander’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Israel Englander’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-159,100
Closed -$8.19M – 3818
2015
Q4 		$8.19M Buy
159,100
+9,100
+6% +$441K 0.02% 1037
2015
Q3 		$6.39M Buy
+150,000
New +$7.24M 0.01% 1196

Israel Englander's PTLA Position: Q3 2020 in Review

Israel Englander sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 683,381 shares — an estimated $12.3M sold.

Israel Englander first reported a position in PTLA in Q2 2013 and held it in 27 quarters. The position peaked at $84.8M in Q4 2015. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Israel Englander reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Israel Englander sold 683,381 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $12.3M.
  • Israel Englander first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 27 quarters.
  • Israel Englander's Portola Pharmaceuticals, Inc. position peaked at $84.8M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.